Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

The Bloc Welcomes Industry Leader, Ane Jones, to Lead New Oncology and Rare Disease Franchise

Written by: | mediasite@prnewswire.com | Dated: Tuesday, April 10th, 2018

 

NEW YORK, April 10, 2018 /PRNewswire/ — Leading health creative agency The Bloc has added industry leader Ane Jones to its management team. As EVP, Managing Director, Jones will head a best-in-class oncology and rare disease franchise at The Bloc. “Oncology and rare diseases have been the focus of recent innovations and breakthroughs requiring agencies to transform to a more nimble model with the patient, science, and creativity at its core,” says Jennifer Matthews, President and Managing Partner. “With Ane, we’ve found the right trailblazer to make this happen.” Jones has over 20 years of US and global experience across oncology brands at every stage of development. Her passion for and depth of knowledge in oncology and hematology, understanding of the unique needs of key stakeholders, and entrepreneurial spirit will be the driving forces of this initiative. Says Jones, “Working in oncology and rare disease has been the most exciting and rewarding experience for me. I am thrilled to join The Bloc and to build our team and presence in this area so that we may help bring future breakthroughs to more patients.” Currently based in Denmark, Jones will be relocating to New York midyear. 

 

About The Bloc: The Bloc is a leading New York–based health creative agency. Founded in 2000 by Susan Miller Viray and Rico Viray, The Bloc is also a founding member of The BlocPartners, the leading global network of independent health creative agencies. For more information, visit www.thebloc.com.

Contact:
Jennifer Matthews: jmatthews@thebloc.com
Source: The Bloc

 

SOURCE The Bloc

Related Links

http://www.thebloc.com

 

PR Newswire source:

https://www.prnewswire.com/news-releases/the-bloc-welcomes-industry-leader-ane-jones-to-lead-new-oncology-and-rare-disease-franchise-300625329.html

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!

Subscribe

Ad Right Bottom